Zimmer Biomet Holdings, Inc. (BVMF:Z1BH34)

Market Cap	98.30B -24.8%
Revenue (ttm)	45.34B +7.2%
Net Income	3.88B -22.0%
EPS	19.55 -19.9%
Shares Out	n/a
PE Ratio	25.31
Forward PE	11.54
Dividend	0.88 (0.76%)
Ex-Dividend Date	Dec 29, 2025

Volume	n/a
Average Volume	52
Open	116.35
Previous Close	116.35
Day's Range	116.35 - 116.35
52-Week Range	115.00 - 157.60
Beta	0.61
RSI	34.15
Earnings Date	Feb 10, 2026

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1927
• Employees: 17,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: Z1BH34

Financial Performance

In 2025, Zimmer Biomet Holdings's revenue was $8.23 billion, an increase of 7.20% compared to the previous year's $7.68 billion. Earnings were $705.10 million, a decrease of -21.98%.

Financial numbers in USD